Ubs Asset Management Americas Inc Ligand Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 50,401 shares of LGND stock, worth $6.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,401
Previous 39,838
26.51%
Holding current value
$6.08 Million
Previous $3.99 Million
35.34%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding LGND
# of Institutions
275Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$347 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$252 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$122 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$107 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$89.7 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.04B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...